drugset / Trial / NCT05525637
Safety and Efficacy Study of YZJ-1139 in Insomnia Disorder
RandomizedParallel-groupDouble-blindTreatment
Summary
The main purpose of this study is to assess efficacy and safety of YZJ-1139 in adult subjects with insomnia disorder. Efficacy will be evaluated on objective and subjective sleep parameters.
Timeline
- Start
- 2021-12-17
- Primary completion
- 2023-07-07
- Completion
- 2023-09-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FAZAMOREXANT | Small molecule | 20 mg | — |
| Subject | FAZAMOREXANT | Small molecule | 40 mg | — |